Down syndrome is a rare cause of neonatal cholestasis. Neonatal cholestasis in a patient with Down syndrome is usually associated with severe liver diseases, such as neonatal hemochromatosis, myeloproliferative disorder and intrahepatic bile duct paucity. We experienced a case of idiopathic neonatal cholestasis in a patient with Down syndrome, which resolved spontaneously. (Pediatr Gastroenterol Hepatol Nutr 2012; 15: 117∼121)
INTRODUCTION
Down syndrome is the most common chromosomal abnormality recognized at birth, and is associated with many anomalies of organ systems including the cardiac, hematologic and gastrointestinal systems. Down syndrome is a rare cause of neonatal cholestasis and the association with neonatal cholestasis has not been well-substantiated. There have been several reported cases of neonatal cholestasis in Down syndrome associated with bile duct paucity, myeloproliferative disorders and neonatal hemochromatosis. The liver diseases in these cases were fatal [1] . To the best of our knowledge, until now benign neonatal cholestasis associated with Down syndrome has not been reported.
We report our experience with a case of idiopathic neonatal cholestasis that spontaneously resolved in a patient with Down syndrome.
CASE REPORT
Patient: A one-day-old female Chief complaint: Hepatosplenomegaly on prenatal ultrasonography Present illness: The patient was born at 38 6/7 weeks of gestation via normal vaginal delivery. The patient was admitted to the neonatal intensive care unit in our hospital because of hepatosplenomegaly on prenatal ultrasonography. Past medical and family history: The patient's prenatal examination did not show any specific abnor- mal findings except hepatosplenomegaly on a prenatal ultrasonography conducted 1 month prior to delivery. The patient's mother was a healthy, 26-year-old woman without any medical problems or use of any medications except iron supplementation. The parents of the patient were not consanguinities and a 3-year-old female sibling was healthy.
Physical examination: The patient's Apgar scores were 6 at 1 minute and 9 at 5 minutes. At the time of birth, the pulse rate was 116 beats/minute, respiratory rate was 42 beats/minute, body temperature was 36 o C and oxygen saturation was 75% on oximetry at room air. Oxygen saturation recovered to 93% at room air at 10 minutes after birth. The birth weight was 2,370 g (＜10 percentile), height was 49.5 cm (50 percentile) and head circumference was 32 cm (＜10 percentile). Physical examination revealed a flat face, low nasal bridge, protruding tongue and short neck (Fig. 1) . Simian creases were evident on both palms. Hepatosplenomegaly was detected on abdominal palpation. We could palpate the liver about 3 cm below the costal margin and also palpate the spleen about 2 cm below the left costal margin on abdominal examination (Fig. 2) . There was no abdominal tenderness. A hypotonic posture was evident. fluids including blood, urine, stool and cerebrospinal fluid were all negative during hospitalization. Trisomy 21 was proven on chromosomal study and direct sequencing of the GATA1 gene was normal.
Abdominal ultrasonography was performed at day 2 following admission due to hepatosplenomegaly, which also revealed hepatosplenomegaly and a prominent hepatic artery. Pathologic findings: We performed biopsies of liver and bone marrow on days 29 and 33 of admission, respectively. On pathologic examination of liver, minimal lobular activity and severe cholestasis were noted (Fig. 3) . But, there were no fibrosis, cellular infiltration or abnormal biliary tract on light and electron microscopy examination. On bone marrow examination, three or four megakaryoblasts were observed in one high power field. However the finding was not sufficient for a diagnosis of myeloproliferative disorder. Hospital course: At the time of admission, liver function tests were within normal limits. But, serum total and direct bilirubin rose to 13.81 mg/dL and 2.01 mg/dL, respectively, without hemolysis on day 2 of hospitalization. Hemoglobin was 18.9 g/dL at the same time. Serum direct bilirubin rose slowly up to 5.42 mg/dL by day 20 of hospitalization ( Fig. 4) , but the stool was yellowish during this period.
The level of GGT increased from 274 U/L at 5-days-of-age to 438 U/L at 1-month-of-age. The levels of AST and ALT fluctuated (Fig. 4) . A second abdominal ultrasonography was performed at day 20 of hospitalization, which revealed hepatomegaly without structural abnormality of biliary tract. The splenomegaly and prominent heptic artery that was evident on the first ultrasonography was not found. We performed liver and bone marrow biopsy after about 1-month of hospitalization because of sustained di- 
DISCUSSION
There are many causes of cholestasis in young infants. Early diagnosis and initiation of appropriate therapy is important, because the effects of this disorder are usually very serious. Down syndrome is also one of the causes of infantile cholestasis, but is very rare. Cholestasis associated with Down syndrome is not well understood and had a fatal clinical course in reported cases [1, 2] . The liver diseases in those cases were associated with myeloproliferative disorder, hemochromatosis and bile duct paucity. Several mechanisms in liver disease associated with Down syndrome that have been suggested are a higher concentration of superoxide dismutase (SOD), higher incidence of viral hepatitis and extramedullary hematopoiesis [1] . In our case, there was no evidence of these mecha-
nisms. An elevated SOD concentration causes continuous radical injuries and iron overload. In other words, increased amount of SOD could be followed by an imbalance in scavenging oxidative stress including glutathione peroxidase and catalase. Imbalance in scavenging oxidative stress may have deleterious effects on oxidative processes including lipid peroxidation. Iron overload may be associated with an increased lipid peroxide formation [3, 4] . [5] .
In our case, the patient displayed relatively good Apgar scores. But, the patient was small for gestational age. Chronic or acute ischemia or hypoxia of the liver in utero as a result of intrauterine growth retardation is a possibility. In addition, bile secretion processes may also be impaired by hepatic hypoxia-ischemia [6] . In a rat model of hepatic hypoxia-ischemia, cholestasis may be caused by biliary canalicular injury or bile duct alteration, which may be paradoxically exacerbated after reperfusion of blood or oxygen to previously ischemic or hypoxic liver [7] . Pathologic examination of the patient's liver biopsy specimen revealed disturbed bile secretion without biliary tract abnormalities.
There was a prominent hepatic artery evident on the first abdominal ultrasonography, which might not affect significantly hepatic hypoxia or ischemia, since the hepatic blood supply generally depends on the portal vein. Two abdominal ultrasonographies did not show a triangular cord sign. But, a periportal echogenecity might not be shown on an ultrasonography in early stage of biliary atresia and, even though there are no triangular cord signs, biliary atresia cannot be ruled out [8] . We did not perform hepatobiliary scintigraphy because of its low specificity, high false positive rate [9] and the patient's yellow stool.
We performed liver biopsy to rule out extrahepatic biliary atresia, biliary paucity, hemochromatosis and myeloproliferative cell depositions because we could not find clear causes of the cholestasis on careful workups. We could rule out the aforementioned severe diseases based on the patient's clinical course and examinations, and initiated conservative care with careful monitoring. Cholestasis improved slowly and the patient was discharged at 2-months-of-age.
We tentatively suggest that another unknown mechanism in Down syndrome and chronic hepatic hypoxia or ischemia in utero under the detected level might affect cholestasis in our case. Further study about cholestasis in Down syndrome may be warranted.
